Replies to post #100628 on Biotech Values

[rkrw]

At least they finally put a date on it.

ARIA's ALK inhibitor is apparently slated for IND in mid-2011.

Pretty disappointing from my point of view.

[BTH]

Exactly.

This company is a joke with their 20 executives collecting $200k a year, and 200 employees all sitting around doing nothing.

Mid-2011. So, you're looking at 2015 at best to see revenue "one" from this drug (if ever).